The company claims to be a market leader in blood screening, adult and pediatric nutrition, left ventricular assist devices, remote heart failure monitoring, and point-of-care testing. Abbott Vascular, Medical Devices and Drugs Amplatzer Steerable Delivery Sheath: A cardiac catheter Assurity MRI Pacem...
Point of care The award-winning i-STAT Alinity point-of-care system is designed to be easy, accurate and connected, providing results in minutes and integrating diagnostic patient-testing directly into the clinical-care pathway. Discoveri‑STATAlinity ...
by Abbott Laboratories, which has doubled its workforce to 285 employees and tripled its business volume according to Abbott Point of Care business marketing director Glen Tineviz. I-Stat has been successful with ...
As the world leader in point-of-care diagnostics, Abbott is adding its expertise and scale to help fight the COVID-19 global pandemic. First introduced in 2014, ID NOW is the leading molecular point-of-care platform for Influenza A & B, Strep A and RSV te...
Abbott Laboratories and Subsidiaries Notes to the Condensed Consolidated Financial Statements March 31, 2023 (Unaudited) Note 3 — Revenue Abbott’s revenues are derived primarily from the sale of a broad line of health care products under short-term receivable arrangements. Abbott has four reportable...
haematology, and transfusion medicine, molecular diagnostics polymerase chain reaction (PCR) instrument systems, point-of-care systems, rapid diagnostics lateral flow testing products in the area of infectious diseases such as SARS-CoV-2, and informatics and automation solutions for use in laboratories....
ID NOW systems are ideally suited to be used on the front lines of the COVID-19 outbreak. Their small size (just 6.6 pounds) enables them to be easily deployed outside the four walls of a traditional hospital such as in the physicians’ office, urgent care clinics or other point-of-car...
Point of Care 284 110 394 (1.7) (1.4) (1.6) (1.7) 3.1 (0.4) Rapid Diagnostics 5,523 2,923 8,446 73.8 7.0 42.9 73.8 15.1 46.7 Diagnostics sales in the third quarter were negatively impacted by year-over-year declines in COVID-19 testing-related sales. Global COV...
Mr. Boudreau has served as Abbott’s Divisional Vice President, Controller, Medical Devices since 2017 and served as Divisional Vice President, Controller and Commercial Support, Point of Care from 2012 to 2017. He joined Abbott in 1997. 29 M Michael D. Dale 高级副总裁-部门 1960 男 本科...
s been placed out in the instrument, so we could add more assays that comes with a much higher margin profile. So, that’s our key area of focus. Molecular is an area of focus. We have been working on expanding the menu in molecular also. And then point of care, one of the most...